|
UNITED
STATES |
OMB APPROVAL |
|
OMB Number: 3235-0582 |
|
|
Expires: April 30, 2009 |
|
|
Estimated average burden hours per response........14.4 |
FORM N-PX
ANNUAL
REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 04889
H&Q Healthcare Investors
(Exact name of registrant as specified in charter)
2 Liberty Square, 9th Floor, Boston, MA |
|
02109 |
(Address of principal executive offices) |
|
(Zip code) |
Laura Woodward
H&Q Healthcare Investors
2 Liberty Square, 9th Floor, Boston MA 02109
(Name and address of agent for service)
Registrants telephone number, including area code: 617 772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/08-6/30/09
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss.239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
HQH N-PX for the period July 1, 2008 to June 30, 2009
CUSIP |
|
Symbol |
Company Name |
|
|
||
004225108 |
|
ACAD |
ACADIA Pharmaceuticals Inc. |
|
|
||
Meeting Date: |
6/12/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Uli Hacksell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Torsten Rasmussen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alan Walton |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
00817Y108 |
|
AET |
Aetna Inc. |
|
|
||
Meeting Date: |
5/29/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Frank M. Clark |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Betsy Z. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Molly J. Coye, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Roger N. Farah |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Barbara Hackman Franklin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jeffrey E. Garten |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Earl G. Graves |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gerald Greenwald |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ellen M. Hancock |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Harrington |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Edward J. Ludwig |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph P. Newhouse |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ronald A. Williams |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of indepdent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Shareholder proposal on cumulative voting |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
4 |
|
Shareholder proposal on nominating a retired Aetna executive to the board |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
00826A109 |
|
AFFY |
Affymax, Inc. |
|
|
||
Meeting Date: |
5/28/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/31/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Ted W. Love, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Arlene M. Morris |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Daniel K. Spiegelman |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of Affymax for its fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
015351109 |
|
ALXN |
Alexion Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/13/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Leonard Bell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Max Link |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph A. Madri |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Larry L. Mathis |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director R. Douglas Norby |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alvin S. Parven |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ruedi E. Waeger |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of appointment by the board of directors of PricewaterhouseCoopers LLP as Alexions independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
016255101 |
|
ALGN |
Align Technology, Inc. |
|
|
||
Meeting Date: |
5/21/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director David E. Collins |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph Lacob |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. Raymond Larkin, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George J. Morrow |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Thomas M. Prescott |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Greg J. Santora |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Warren S. Thaler |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.s independent registered public accountants for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
2
01642T108 |
|
ALKS |
Alkermes, Inc. |
|
|
||
Meeting Date: |
10/7/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
7/14/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Floyd E. Bloom |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert A. Breyer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Geraldine Henwood |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Paul J. Mitchell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard F. Pops |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alexander Rich |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dvid A. Broeckert |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Mark B. Skaletsky |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael A. Wall |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David W. Anstice |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To approve the Alkermes 2008 stock option and incentive plan |
|
For |
|
Yes |
|
Against |
|
Management |
3 |
|
To ratify PricewaterhouseCoopers LLP as the companys independent registered public accountant for fiscal year 2009 |
|
For |
|
Yes |
|
For |
|
Management |
031162100 |
|
AMGN |
Amgen Inc. |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Dr. David Baltimore |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frank J. Biondi, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Francois de Carbonnel |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jerry D. Choate |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Vance D. Coffman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frederick W. Gluck |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frank C. Herringer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Gilbert S. Omenn |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Judity C. Pelham |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Adm. J. paul Reason, UsN |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Leonard D. Schaeffer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin W. Sharer |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve the proposed 2009 equity incentive plan, which authorizes the issuance of 100,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
To approve the proposed amendment to our restated certificate of incorporation, as amended, which reduces the sixty-six and two-thirds percent voting requirement to a simple majority voting requirement for approval of certain business combinations |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Stockholder proposal #1 to amend our bylaws to permit 10% of our outstanding common stock the ability to call special meetings |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
5 |
|
Stockholder proposal #2 to change our jurisdiction of incorporation from Delaware to North Dakota |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
3
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/27/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director M. Kathleen Behrens |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Charles M. Fleischman |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Jay Sherwood |
|
Unkown |
|
Yes |
|
Withhold |
|
Opposition |
1 |
|
Elect director Dr. A.J. Denner |
|
Unkown |
|
Yes |
|
Withhold |
|
Opposition |
1 |
|
Elect director Dr. T.F. Deuel |
|
Unkown |
|
Yes |
|
Withhold |
|
Opposition |
1 |
|
Elect director Adrian Adams |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Teresa Beck |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director D.M. Bradbury |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Paul N. Clark |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Paulo F. Costa |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Karin Eastham |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect directo Jay S. Skyler |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
2 |
|
Proposal to adopt the companys 2009 equity incentive plan as described in the proxy statement |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
3 |
|
2001 employee stock purchase plan proposal as described in the proxy statement |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
4 |
|
Proposal to ratify Ernst & Young LLP as the independent public registered accounting firm for Amylin for the year ending December 31, 2009 |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
5 |
|
Icahn reincorporation proposal as described in the proxy statement |
|
Unkown |
|
Yes |
|
Against |
|
Opposition |
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/27/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Adrian Adams |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Steven R. Altman |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Teresa Beck |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Daniel M. Bradbury |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Paul N. Clark |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Joseph C. Cook, Jr. |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Paulo F. Costa |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Karin Eastham |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director James R. Gavin III |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Jay S. Skyler |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Joseph P. Sullivan |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director James N. Wilson |
|
For |
|
No |
|
None |
|
Management |
2 |
|
To approve the companys 2009 equity incentive plan |
|
For |
|
No |
|
None |
|
Management |
3 |
|
To approve an increase of 1,500,000 shares in the aggregate number of shares of the companys common stock authorized for issuance under the companys 2001 employee stock purchase plan |
|
For |
|
No |
|
None |
|
Management |
4 |
|
To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2009 |
|
For |
|
No |
|
None |
|
Management |
5 |
|
Stockholder proposal to change the companys jurisdiction of incorporation from Delaware to North Dakota |
|
Against |
|
No |
|
None |
|
Stockholder |
4
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/27/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Alexander J. Denner |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Thomas F. Deuel |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director M.K. Behrens |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director C.M. Fleischman |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Jay Sherwood |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Adrian Adams |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Teresa Beck |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director D.M. Bradbury |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Paul N. Clark |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Paulo F. Costa |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Karin Eastham |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Jay S. Skyler |
|
Unkown |
|
No |
|
None |
|
Opposition |
2 |
|
Amylins equity incentive plan |
|
Unkown |
|
No |
|
None |
|
Opposition |
3 |
|
Amendment to the 2001 employee stock purchase plan |
|
Unkown |
|
No |
|
None |
|
Opposition |
4 |
|
Ratification of appointment of independent registered public accounting firm |
|
Unkown |
|
No |
|
None |
|
Opposition |
5 |
|
North Dakota reincorporation proposal |
|
Unkown |
|
No |
|
None |
|
Stockholder |
038149100 |
|
ABI |
Applied Biosystems Inc. |
|
|
||
Meeting Date: |
10/16/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
9/5/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approve and adopt the agreement and plan of merger, as amended, by and among Invitrogen Corporation, Atom Acquisition, LLC, and Applied Biosystems Inc., as such agreement may be amended from time to time, and to approve the merger of Applied Biosystems Inc. with and into Atom Acquisition, LLC, all as more fully described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To adjourn the Applied Biosystems Inc. special meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes for the foregoing proposal |
|
For |
|
Yes |
|
For |
|
Management |
04744L106 |
|
ATHX |
Athersys, Inc. |
|
|
||
Meeting Date: |
6/18/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Gil Van Bokkelen |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Jordan S. Davis |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director John J. Harrington |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Floyed D. Loop |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director George M. Milne, Jr. |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director William C. Mulligan |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Lorin J. Randall |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Michael Sheffery |
|
For |
|
No |
|
None |
|
Management |
2 |
|
Ratification for Ernst & Young LLP as auditors |
|
For |
|
No |
|
None |
|
Management |
5
05334D107 |
|
AUXL |
Auxilium Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/10/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Rolf A. Classon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Al Altomari |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Armando Anido |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Edwin A. Bescherer, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director P.O. Chambon, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Oliver S. Fetzer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Renato Fuchs, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dennis Langer, MD, JD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William T. McKee |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approve amendment and restatement of Auxilium Pharmaceuticals, Inc. 2004 equity compensation plan to increase number of shares of company common stock authorized for issuance under the plan by 2,650,000 shares from 8,000,000 to 10,650,000 shares, subject to limitation that of those 2,650,000 shares only 700,000 shares may be issued pursuant to stock awards, stock units |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
To ratify the selection by the audit and compliance committee of the companys board of directors of PricewaterhouseCoopers LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
05346P106 |
|
AVRX |
Avalon Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/28/2009 |
|
Meeting Type: |
Special |
|||
Record Date: |
4/13/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To consider and vote upon a proposal to adopt the agreement and plan of merger and reorganization, dated as of October 27, 2008, as amended, by and among Clinical Data, Inc., API Acquisition Sub II, LLC, and Avalon Pharmaceuticals, Inc., pursuant to which API will merge with and into Avalon, with Avalon being the surviving corporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To consider and vote upon a proposal to adjourn the special meeting to a later date or time, if necessary or appropriate, to solicit additional proxies in the event there are insufficient votes at the time of the special meeting to adopt the merger agreement |
|
For |
|
Yes |
|
For |
|
Management |
6
068306109 |
|
BRL |
Barr Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
11/21/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
10/10/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Adoption of the agreement and plan of merger, dated as of July 18, 2008 by and among Barr Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Ltd. and Boron Acquisition Corp., as it may be amended from time to time |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to adopt the agreement and plan of merger referred to in proposal 1 |
|
For |
|
Yes |
|
For |
|
Management |
09062X103 |
|
BIIB |
Biogen Idec |
|
|
||
Meeting Date: |
6/3/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/6/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Lawrence C. Best |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alan B. Glassberg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert W. Pangia |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William D. Young |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of PricewaterhouseCoopers LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve amendments to the companys bylaws to change the voting standard for the election of directors in uncontested elections from a plurality to a majority standard |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Shareholder proposal to amend the companys bylaws to fix the size of the board at 13 members and remove the boards ability to change the size of the board |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
5 |
|
Shareholder proposal that the company reincorporate from Deleware to North Dakota and elect to be subject to the North Dakota publicly traded corporations act |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
09062X103 |
|
BIIB |
Biogen Idec |
|
|
||
Meeting Date: |
6/3/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/6/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Alexander J. Denner |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Richard C. Mulligan |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Thomas F. Deuel |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director David Sidransky |
|
Unkown |
|
No |
|
None |
|
Opposition |
2 |
|
Approval of the Icahn bylaws amendments |
|
Unkown |
|
No |
|
None |
|
Opposition |
3 |
|
Approval of the North Dakota Reincorporation resolution |
|
Unkown |
|
No |
|
None |
|
Opposition |
4 |
|
Ratification of independent registered public accounting firm |
|
Unkown |
|
No |
|
None |
|
Opposition |
5 |
|
Approval of the Biogen bylaw amendment |
|
Unkown |
|
No |
|
None |
|
Opposition |
7
14159L103 |
|
BEAT |
CardioNet, Inc. |
|
|
||
Meeting Date: |
10/23/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/10/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect Director Ronald A. Ahrens |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect Fred Middleton |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection by the Audit Committee of our board of directors of Ernst & Young LLP as our independent auditors for the fiscal year ending December 31, 2008 |
|
For |
|
Yes |
|
For |
|
Management |
14159L103 |
|
BEAT |
CardioNet, Inc. |
|
|
||
Meeting Date: |
5/8/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Randy H. Thurman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kirk E. Gorman |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as the independent auditors for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve an amendment to the CardioNet, Inc. 2008 non-employee directors stock option plan and all outstanding options granted thereunder to date to extend the post-termination exercise period for vested options from three months following directors termination of service to the remainder of the option term in effect at the time of the directors termination of service |
|
For |
|
Yes |
|
Against |
|
Management |
14888B103 |
|
CHSI |
Catalyst Health Solutions Inc. |
|
|
||
Meeting Date: |
6/1/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/3/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Steven B. Epstein |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael R. McDonnell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dale B. Wolf |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
The approval of reservation of additional 100,000 shares of company stock for issuance under the companys 2004 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
The ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants of Catalyst Health Solutions, Inc. for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
8
151020104 |
|
CELG |
Celgene Corporation |
|
|
||
Meeting Date: |
6/17/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/21/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Sol J. Barer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Hugin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael D. Casey |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Rodman L. Drake |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director A.H. Hayes, Jr., MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gilla Kaplan, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James J. Loughlin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ernest Mario, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Walter L. Robb, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of KPMG LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of an amendment and restatement of the companys 2008 stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Stockholder proposal regarding the voting standard for director elections |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
156708109 |
|
CEPH |
Cephalon, Inc. |
|
|
||
Meeting Date: |
5/12/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/17/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director F. Baldino, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William P. Egan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Martyn D. Greenacre |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Vaughn M. Kailian |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin E. Moley |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.A. Sanders, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gail R. Wilensky, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dennis L. Winger |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of amendment to the 2004 equity compensation plan increasing the number of shares authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
9
N/A |
|
N/A |
Concentric Medical, Inc. |
|
|
|
Action by Written Consent: |
12/15/2008 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of issuance of preferred stock |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of waiver of right of first refusal |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Approval of increase to stock plan |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approval of indemnification agreements |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
Omnibus resolution |
|
For |
|
Yes |
|
For |
|
Management |
222083107 |
|
CGRB |
Cougar Biotechnology, Inc. |
|
|
||
Meeting Date: |
10/28/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
9/9/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of proposed amendments to the companys 2003 stock option plan as described in the accompanying proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
229678107 |
|
CBST |
Cubist Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/4/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Kenneth Bate |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nancy Hutson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Martin Soeters |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
A proposal to amend the amended and restated 1997 employee stock purchase plan, or ESPP, to increase the number of shares issuable under the ESPP by 500,000 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
A proposal to amend out amended and restated 2002 directors equity incentive plan to extend the term of the directors plan by 3 years and to increase the number of shares issuable under the directors plan by 400,000 |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
A proposal to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
10
122650100 |
|
CVS |
CVS Caremark Corporation |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/12/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Edwin M. Banks |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. David Brown II |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David W. Dorman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kristen G. Williams |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Marian L. Heard |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William H. Joyce |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jean-Pierre Millon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Terrence Murray |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.A. Lance Piccolo |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Sheli Z. Rosenberg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Thomas M. Ryan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Swift |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the 2009 fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Stockholder proposal regarding special stockholder meetings |
|
Against |
|
Yes |
|
For |
|
Stockholder |
4 |
|
Stockholder proposal regarding independent chairman of the board |
|
Against |
|
Yes |
|
For |
|
Stockholder |
5 |
|
Stockholder proposal regarding political contributions and expenditures |
|
Against |
|
Yes |
|
For |
|
Stockholder |
6 |
|
Stockholder proposal regarding advisory stockholder vote on executive compensation |
|
Against |
|
Yes |
|
For |
|
Stockholder |
278856109 |
|
ECLP |
Eclipsys Corp. |
|
|
||
Meeting Date: |
5/13/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/20/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director John T. Casey |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jay B. Pieper |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of PricewaterhouseCoopers LLP by the board of directors as the companys independent registered public accounting firm for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
N/A |
|
N/A |
Eleme Medical, Inc. |
|
|
|
Action by Written Consent: |
8/1/2008 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amendment to certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of general authorization |
|
For |
|
Yes |
|
For |
|
Management |
11
30161Q104 |
|
EXEL |
Exelixis, Inc. |
|
|
||
Meeting Date: |
5/13/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Charles Cohen, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George Poste, DVM, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jack L. Wyszomierski |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as Exelixis independent registered public accounting firm for the fiscal year ending January 1, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve an amendment to the Exelixis, Inc. 2000 employee stock purchase plan to increase the number of shares of common stock reserved for issuance under the 2000 employee stock purchase plan by 5,000,000 shares |
|
For |
|
Yes |
|
Against |
|
Management |
4 |
|
To approve the amendment and restatement of the Exelixis, Inc. 2000 equity incentive plan |
|
For |
|
Yes |
|
Against |
|
Management |
5 |
|
To approve a proposed exchange of certain outstanding stock options for a reduced number of replacement stock options to be granted under the 2000 equity incentive plan with an exercise price equal to the fair market value of Exelixis common stock at the time of the exchange |
|
For |
|
Yes |
|
For |
|
Management |
N/A |
|
N/A |
FlowCardia, Inc. |
|
|
|
Action by Written Consent: |
3/3/2009 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amendment to amend and restated equity incentive plan |
|
For |
|
No |
|
None |
|
Management |
2 |
|
General authority and ratification |
|
For |
|
No |
|
None |
|
Management |
345838106 |
|
FRX |
Forest Laboratories, Inc. |
|
|
||
Meeting Date: |
8/11/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
6/19/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Howard Solomon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director L.S. Olanoff, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nesli Basgoz, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William J. Candee, III |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George S. Cohan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dan L. Goldwasser |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kenneth E. Goodman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Lester B. Salans, MD |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Adoption of the amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Ratification of BDO Seidman, LLP as independent registered public acocunting firm |
|
For |
|
Yes |
|
For |
|
Management |
12
372917104 |
|
GENZ |
Genzyme Coporation |
|
|
||
Meeting Date: |
5/21/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/31/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Douglas A. Berthiaume |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gail K. Boudreaux |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert J. Carpenter |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Charles L. Cooney |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Victor J. Dzau |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Senator Connie Mack III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Richard F. Syron |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Henri A. Termeer |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,500,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
A proposal to approve the 2009 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
A proposal to ratify the audit committees selection of independent auditors for 2009 (PricewaterhouseCoopers LLP) |
|
For |
|
Yes |
|
For |
|
Management |
|
375558103 |
|
GILD |
Gilead Sciences, Inc. |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Paul Berg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John F. Cogan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Etienne F. Davignon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director James M. Denny |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Carla A. Hills |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John W. Madigan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John C. Martin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gordon E. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Nicholas G. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Richard J. Whitley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gayle E. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP by the audit committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve an amendment to Gileads 2004 equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
13
436440101 |
|
HOLX |
Hologic, Inc. |
|
|
||
Meeting Date: |
3/4/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
1/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director John W. Cumming |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert A. Cascella |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director David R. Lavance, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Nancy L. Leaming |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Lawrence M. Levy |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Glenn P. Muir |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Elaine S. Ullian |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Sally W. Crawford |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Wayne Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To consider and act upon a stock option exchange program for eligible employees |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To consider and act upon the adjournment of the annual meeting, including if necessary, to solicit additional proxies in favor of the foregoing proposals, as described in the accompanying proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
45103T107 |
|
ICLR |
Icon Plc |
|
|
||
Meeting Date: |
7/21/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
N/A |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To receive the accounts and reports |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To re-elect Dr. John Climax |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To re-elect Edward Roberts |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To re-elect Prof. Dermot Kelleher |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
To authorise the fixing of the Auditors renumeration |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
To approve the 2008 employee restricted share unit plan |
|
For |
|
Yes |
|
Against |
|
Management |
|
7 |
|
To approve the employee share option plan 2008 |
|
For |
|
Yes |
|
Against |
|
Management |
|
8 |
|
Tp approve the consultants share option plan 2008 |
|
For |
|
Yes |
|
Against |
|
Management |
|
9 |
|
To increase the authorised share capital |
|
For |
|
Yes |
|
Against |
|
Management |
|
10 |
|
To approve the capitalisation and bonus issue |
|
For |
|
Yes |
|
For |
|
Management |
|
11 |
|
To authorise the company to allot shares |
|
For |
|
Yes |
|
For |
|
Management |
|
12 |
|
To disapply the statutory pre-emption rights |
|
For |
|
Yes |
|
For |
|
Management |
|
13 |
|
To authorise the company to make market purchases of shares |
|
For |
|
Yes |
|
For |
|
Management |
|
14 |
|
To authorise the chairman to have a casting vote such other business as may come before the meeting |
|
For |
|
Yes |
|
For |
|
Management |
|
14
45168D104 |
|
IDXX |
IDEXX Laboratories, Inc. |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director William T. End |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Barry C. Johnson, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Brian P. McKeon |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Adoption of the IDEXX Laboratories, Inc. 2009 stock incentive plan to approve |
|
|
|
|
|
|
|
|
|
|
|
and adopt the 2009 stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Amendment to the IDEXX Laboratories, Inc. 1997 employee stock purchase plan to approve and adopt a proposed amendment to our 1997 employee stock purchase plan to increase the number of shares authorized for issuance under the plan from 1,240,000 shares to 1,590,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To ratify the selection by the audit committee of the board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
To conduct such other business as may properly come before the annual meeting |
|
For |
|
Yes |
|
For |
|
Management |
|
452327109 |
|
ILMN |
Illumina, Inc. |
|
|
||
Meeting Date: |
5/8/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director A. Blaine Bowman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Karin Eastham |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Jay T. Flatley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director William H. Rastetter |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratify the appointment of Ernst & Young LLP as independent auditors |
|
For |
|
Yes |
|
For |
|
Management |
|
46120E602 |
|
ISRG |
Intuitive Surgical, Inc. |
|
|
||
Meeting Date: |
4/22/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Gary S. Guthart |
|
Yes |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Mark J. Rubash |
|
Yes |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Lonnie M. Smith |
|
Yes |
|
Yes |
|
For |
|
Management |
|
15
46126P106 |
|
IMA |
Inverness Medical Innovations, Inc. |
|
|
||
Meeting Date: |
6/18/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Carol R. Goldberg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director James Roosevelt, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Ron Zwanziger |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of an increase to the number of shares of common stock available for issuance under the Inverness Medical Innovations, Inc. 2001 stock option and incentive plan by 1,000,000 from 11,074,081 to 12,074,081 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of an increase to the number of shares of common stock available for issuance under the Inverness Medical Innovations, Inc. 2001 employee stock purchase plan by 1,000,000 from 1,000,000 to 2,000,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Ratification of the appointment of BDO Seidman, LLP as the independent registered public accountants for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
50540R409 |
|
LH |
Laboratory Corp. of America Holdings |
|
|||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/13/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Thomas P. MacMahon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Kerrii B. Anderson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Jean-Luc Belingard |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director David P. King |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Wendy E. Lane |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert E. Mittelstaedt, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Arthur H. Rubenstein, Mbbch |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director M. Keith Weikel, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director R. Sanders Williams, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as the companys independent registered public accounting firm for 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
16
53217V109 |
|
LIFE |
Life Technologies Corporation |
|
|||
Meeting Date: |
4/30/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Donald W. Grimm |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gregory T. Lucier |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Per A. Peterson, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director William S. Shanahan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Arnold J. Levine, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the apointment of Ernst & Young LLP as independent auditors of |
|
|
|
|
|
|
|
|
|
|
|
the company for fiscal year 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Amendment of Invitrogen Corporation 1998 employee stock purchase plan |
|
For |
|
Yes |
|
Against |
|
Management |
|
4 |
|
Adoption of Life Technologies Corporation 1999 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Adoption of the companys 2009 equity incentive plan |
|
For |
|
Yes |
|
Against |
|
Management |
|
N/A |
|
N/A |
Magellan Biosciences, Inc. |
|
|
||
Action by Written Consent: |
4/2/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of amendment and restatement of the companys amended and restated certificate |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of financing |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of warrants |
|
For |
|
Yes |
|
For |
|
Management |
|
572901106 |
|
MATK |
Martek Biosciences Corporation |
|
|||
Meeting Date: |
3/19/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
1/21/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Harry J. DAndrea |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director James R. Beery |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Michael G. Devine |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Steve Dubin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert J. Flanagan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Polly B. Kawalek |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Jerome C. Keller |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Douglas J. Macmaster, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert H. Mayer |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Eugene H. Rotberg |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
17
574795100 |
|
MASI |
Masimo Corporation |
|
|||
Meeting Date: |
6/16/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Edward L. Cahill |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert Coleman, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Grant Thornton LLP as the companys independent auditors for fiscal year 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
58405U102 |
|
MHS |
Medco Health Solutions, Inc. |
|
|||
Meeting Date: |
5/21/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/26/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Charles M. Lillis |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director William L. Roper |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director David D. Stevens |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the company for the 2009 fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of executive annual incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
584688105 |
|
MDCO |
Medicines Company |
|
|||
Meeting Date: |
5/28/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/3/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Armin M. Kessler |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert G. Savage |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Melvin K. Spigelman |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approve an amendment to the companys 2000 employee stock purchase plan to increase the number of shares of common stock authorized for issuance under the plan from 505,000 shares to 805,500 shares |
|
For |
|
Yes |
|
Against |
|
Management |
|
3 |
|
Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
628530107 |
|
MYL |
Mylan, Inc. |
|
|||
Meeting Date: |
5/7/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/20/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Milan Puskar |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert J. Coury |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Wendy Cameron |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Neil Dimick, CPA |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Doug Leech, CPA |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Joseph C. Maroon, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Rodney L. Piatt, CPA |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director C.B. Todd |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director R.L. Vanderveen, Ph.D. R.Ph. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment to the companys articles of incorporation to increase authorized shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approve an amendment to the companys 2003 long-term incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Approve an amendment to the companys bylaws regarding voting in uncontested director elections |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
|
18
62855J104 |
|
MYGN |
Myriad Genetics, Inc. |
|
|||
Meeting Date: |
11/13/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/26/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Walter Gilbert, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director D.H. Langer, MD, J.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to amend the restated certificate of incorporation, as amended, to increase the number of authorized common stock from 60,000,000 shares to 150,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Proposal to amend the 2003 employee, director and consutant stock option plan to increase the number of shares of common stock available for issuance thereunder by 1,500,000 shares |
|
For |
|
Yes |
|
Against |
|
Management |
|
4 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending June 30, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
654798503 |
|
NTMD |
Nitromed, Inc. |
|
|||
Meeting Date: |
4/22/2009 |
|
Meeting Type: |
Special |
|||
Record Date: |
3/6/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Agreement and plan of merger, by and among Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Special Situations Fund, L.P., Deerfield Special Situations Fund International Limited, NTMD Parent Acquisition Corp., NTMD Acquisition Corp. and Nitromed, a copy of which is attached as annex A to the accompanying proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an adjournment of the Nitromed special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of proposal No. 1 |
|
For |
|
Yes |
|
For |
|
Management |
|
19
654798503 |
|
NTMD |
Nitromed, Inc. |
|
|||
Meeting Date: |
1/27/2009 |
|
Meeting Type: |
Special |
|||
Record Date: |
12/11/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To approve the sale of substantially all of Nitromeds assets pursuant to the purchase and sale agreement, dated October 22, 2008, by and between Nitromed and JHP Pharmaceuticals, LLC, a copy of which is attached as Annex A to the accompanying proxy statement. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an adjournment of the Nitromed special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of proposal No. 1 |
|
For |
|
Yes |
|
For |
|
Management |
|
671040103 |
|
OSIP |
OSI Pharmaceuticals, Inc. |
|
|||
Meeting Date: |
6/17/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/22/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Robert A. Ingram |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Colin Goddard, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Santo J. Costa |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Joseph Klein, III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Kenneth B. Lee, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Viren Mehta |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director David W. Niemiec |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director H.M. Pinedo, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Katharine B. Stevenson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John P. White |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the appointment of KPMG LLP as the independent registered public accounting firm of the corporation for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
20
709754105 |
|
PPCO |
Penwest Pharmaceuticals Co. |
|
|||
Meeting Date: |
6/10/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/7/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Kevin C. Tang |
|
Unknown |
|
Yes |
|
For |
|
Opposition |
|
1 |
|
Elect director Joseph Edelman |
|
Unknown |
|
Yes |
|
For |
|
Opposition |
|
1 |
|
Elect directo Andrew D. Levin, MD, Ph.D. |
|
Unknown |
|
Yes |
|
For |
|
Opposition |
|
2 |
|
To approve the proposed amendment to the companys bylaws to set the date of all future annual meetings of shareholders on April 30th or the following business day |
|
Against |
|
Yes |
|
For |
|
Opposition |
|
3 |
|
To approve the proposed amendment to the companys bylaws to require the approval of 75% of the directors in office to various specified actions |
|
Against |
|
Yes |
|
For |
|
Opposition |
|
3 |
|
To approve the proposed amendment to the companys bylaws to require the approval of 81% of the directors in office to various specified actions |
|
Against |
|
Yes |
|
For |
|
Opposition |
|
4 |
|
To approve the following shareholder resolution: Now, therefore, be it resolved, that the shareholders of the company hereby request that the Board of Directors of the company take prompt and thoughtful action to preserve shareholder value by immediately winding down substantially all of the companys operations so that the full value of the Opana ER royalty income stream will be retained for the benefit of shareholders |
|
Against |
|
Yes |
|
For |
|
Stockholder |
|
5 |
|
To ratify the appointment of Ernst & Young LLP as independent public accountants of the company for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Opposition |
|
6 |
|
To approve the proposed amendment to the companys 1997 stock purchase plan |
|
For |
|
Yes |
|
For |
|
Opposition |
|
709754105 |
|
PPCO |
Penwest Pharmaceuticals Co. |
|
|||
Meeting Date: |
6/10/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/7/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director W. James OShea |
|
For |
|
No |
|
None |
|
Management |
|
1 |
|
Elect director Joseph Edelman |
|
For |
|
No |
|
None |
|
Management |
|
2 |
|
Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the current fiscal year |
|
For |
|
No |
|
None |
|
Management |
|
3 |
|
Approval of the proposed amendment to the Companys 1997 employee stock purchase plan |
|
For |
|
No |
|
None |
|
Management |
|
714046109 |
|
PKI |
PerkinElmer, Inc. |
|
|||
Meeting Date: |
4/28/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/2/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Robert F. Friel |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Nicholas A. Lopardo |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Alexis P. Michas |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director James C. Mullen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Dr. Vicki L. Sato |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gabriel Schmergel |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Kenton J. Sicchitano |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Patrick J. Sullivan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director G. Robert Tod |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Deloitte & Touche LLP as Perkinelmers independent auditors for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the Perkinelmer, Inc. 2009 incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
21
717081103 |
|
PFE |
Pfizer Inc. |
|
|||
Meeting Date: |
4/23/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Dennis A. Ausiello |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Michael S. Brown |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director M. Anthony Burns |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert N. Burt |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director W. Don Cornwell |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director William H. Gray, III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Constance J. Horner |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director James M. Kilts |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Jeffrey B. Kindler |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director George A. Lorch |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Dana G. Mead |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Suzanne Nora Johnson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Stephen W. Sanger |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director William C. Steere, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the selection of KPMG LLP as independent registered public accounting firm for 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Proposal to approve the Pfizer Inc. 2004 stock plan, as amended and restated |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Shareholder proposal regarding stock options |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
|
5 |
|
Shareholder proposal regarding advisory vote on executive compensation |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
|
6 |
|
Shareholder proposal regarding cumulative voting |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
|
7 |
|
Shareholder proposal regarding special shareholder meetings |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
|
717124101 |
|
PPDI |
Pharmaceutical Product Development, Inc. |
|
|||
Meeting Date: |
5/20/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/20/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Stuart Bondurant, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Frederic N. Eshelman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Frederick Frank |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director General David L. Grange |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Catherine M. Klema |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Terry Magnuson, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Ernest Mario, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John A. McNeill, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment and restatement of the companys 1995 equity compensation plan which, among other things, increases the number of shares of our common stock reserved for issuance under the plan by 8,300,000 from 21,259,004 shares to 29,559,004 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification of the appointment of Deloitte & Touche LLP as the companys independent registered public accounting firm for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the meeting |
|
For |
|
Yes |
|
Abstain |
|
Management |
|
22
863667101 |
|
SYK |
Stryker Corporation |
|
|||
Meeting Date: |
4/29/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/2/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director John W. Brown |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Howard E. Cox, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Donald M. Engelman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Louise L. Francesconi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Howard L. Lance |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Stephen P. Macmillan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director William U. Parfet |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Ronda E. Stryker |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
N/A |
|
N/A |
Syntiro Healthcare Services |
|
|
||
Action by Written Consent: |
6/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of restated charter of the corporation |
|
For |
|
No |
|
None |
|
Management |
|
2 |
|
Authorization of officers to execute the actions in forgoing resolution |
|
For |
|
No |
|
None |
|
Management |
|
3 |
|
Approval of actions taken by officers with regard to transaction in forgoing resolution |
|
For |
|
No |
|
None |
|
Management |
|
881624209 |
|
TEVA |
Teva Pharmaceutical Industries Ltd. |
|
|||
Meeting Date: |
9/25/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
8/18/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To appoint Joseph Nitzani as a statutory independent director for a term of three years |
|
For |
|
Yes |
|
For |
|
Management |
|
23
881624209 |
|
TEVA |
Teva Pharmaceutical Industries Ltd. |
|
|||
Meeting Date: |
6/22/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
5/13/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To approve the board of directors recommendation that the cash dividend for year ended December 31, 2008, which was paid in four installments and aggregated NIS 1.95 (approximately $0.525, according to the applicable exchange rates) per ordinary share (or ADS), be delcared final |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Elect director Dr. Phillip Frost |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Elect director Roger Abravanel |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Elect director Prof. Elon Kohlberg |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Elect director Prof. Yitzhak Peterburg |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Elect director Erez Vigoman |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as the companys independent registered public accounting firm until the 2010 annual meeting of shareholders and to authorize the board to determine their compensation provided such compensation is also approved by the audit committee |
|
For |
|
Yes |
|
For |
|
Management |
|
N/A |
|
N/A |
Therox, Inc. |
|
|
||
Action by Written Consent: |
1/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Increase shares issuable under stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment to and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of amendment to third amended and restated investors rights and voting agreement |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Omnibus resolutions |
|
For |
|
Yes |
|
For |
|
Management |
|
91307C102 |
|
UTHR |
United Therapeutics Corporation |
|
|||
Meeting Date: |
6/26/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/29/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Ray Kurzweil |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Martine Rothblatt |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Louis Sullivan |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Vote to ratify Ernst & Young LLP as United Therapeutics Corporations independent registered public accounting firm for 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
24
92532F100 |
|
VRTX |
Vertex Pharmaceuticals Incorporated |
|
|||
Meeting Date: |
5/14/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/17/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Roger W. Brimblecombe |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Bruce I. Sachs |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
The approval of the amendments to the amended and restated 2006 stock and option plan that increase the number of shares of common stock authorized for issuance under the plan by 7,700,000 shares from 13,902,380 shares to 21,602,380 shares and increase the maximum number of shares a participant may receive in a calendar year under the plan from 600,000 to 700,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
The ratification of the appointment of Ernst & Young LLP as our independent registereted public accounting firm for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
94973V107 |
|
WLP |
WellPoint, Inc. |
|
|||
Meeting Date: |
5/20/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/18/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Lenox D. Baker, Jr., MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Susan B. Bayh |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Larry C. Glasscock |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Julie A. Hill |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Ramiro G. Peru |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the company for 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the proposed WellPoint incentive compensation plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the WellPoint employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
To consider a shareholder proposal concerning an advisory resolution on compensation of named executive officers if properly presented at the meeting |
|
Against |
|
Yes |
|
For |
|
Stockholder |
|
25
98411C100 |
|
XNPT |
Xenoport, Inc. |
|
|||
Meeting Date: |
5/7/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/20/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Catherine J. Friedman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Per G.H. Lofberg |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the Audit Committee of the board of directors of Ernst & Young LLP as the companys independent registered public accoutiing firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
N/A |
|
N/A |
Xoft, Inc. |
|
|
||
Action by Written Consent: |
6/11/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of note and warrant financing |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of conversion of preferred stock |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Approval of waiver of right of first refusal |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Approval of indemnification agreements |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
Omnibus resolutions |
|
For |
|
Yes |
|
For |
|
Management |
|
26
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) |
H&Q Healthcare Investors |
||||
|
|||||
By (Signature and Title)* |
|
|
|||
|
|
(Daniel Omstead, President) |
|||
|
/s/ Daniel Omstead |
||||
|
|||||
Date |
8/31/09 |
||||
*Print the name and title of each signing officer under his or her signature.
2